Document Detail


Evaluation of AJCC tumor staging for cutaneous squamous cell carcinoma and a proposed alternative tumor staging system.
MedLine Citation:
PMID:  23325457     Owner:  NLM     Status:  MEDLINE    
Abstract/OtherAbstract:
IMPORTANCE: This study proposes an alternative tumor staging system for cutaneous squamous cell carcinoma (CSCC) that more precisely defines the small subset of tumors with a high risk of metastasis and death.
OBJECTIVE: To identify risk factors for poor outcomes in CSCC and evaluate the 2010 American Joint Committee on Cancer (AJCC) tumor (T) staging system's ability to stratify occurrence of these outcomes.
DESIGN: Retrospective cohort study.
SETTING: A single academic hospital.
PARTICIPANTS: Study participants were identified via a pathology and dermatopathology database search for patients diagnosed as having high-risk CSCC.
RESULTS: Two hundred fifty-six primary high-risk CSCCs were included. Outcomes for AJCC tumor stages T2 to T4 were statistically indistinguishable because only 4 cases (<2% of the cohort) were AJCC stages T3 or T4, which require bone invasion. Subsequently, the bulk of poor outcomes (83% of nodal metastases, 92% of deaths from CSCC) occurred in AJCC stage T2 cases. An alternative tumor staging system was developed with the aim of better stratifying this stage T2 group. Four risk factors were found to be statistically independent prognostic factors for at least 2 outcomes of interest in multivariate modeling. These factors (poor differentiation, perineural invasion, tumor diameter ≥2 cm, invasion beyond subcutaneous fat) were incorporated in the alternative staging with 0 factors indicating T1, 1 factor indicating T2a; 2 to 3 factors, T2b; and 4 factors or bone invasion, T3. Stages T2a and T2b significantly differed in incidences of all 4 end points. Stage T2b tumors comprised only 19% of the cohort but accounted for 72% of nodal metastases and 83% of deaths from CSCC.
CONCLUSIONS AND RELEVANCE: The proposed alternative tumor staging system offers improved prognostic discrimination via stratification of stage T2 tumors. Validation in other cohorts is needed. Meanwhile, stage T2b tumors are responsible for most poor outcomes and may be a focus of high-risk CSCC study.
Authors:
Anokhi Jambusaria-Pahlajani; Peter A Kanetsky; Pritesh S Karia; Wei-Ting Hwang; Joel M Gelfand; Faith M Whalen; Rosalie Elenitsas; Xiaowei Xu; Chrysalyne D Schmults
Related Documents :
10896207 - Prognostic value of the expression of tumor suppressor genes p53, p21, p16 and prb, and...
14720137 - Immunohistochemical analysis of centromere protein f expression in buccal and gingival ...
10212807 - Morphometric analysis of bromodeoxyuridine distribution and cell density in the rat dun...
22121907 - Synthesis and evaluation of folate-based chlorambucil delivery systems for tumor-target...
9827357 - Mesotheliomas of tunica vaginalis testis of fischer 344 (f344) rats treated with acryla...
16352617 - Significance of cox-2 expression in human esophageal squamous cell carcinoma.
Publication Detail:
Type:  Comparative Study; Evaluation Studies; Journal Article; Research Support, N.I.H., Extramural    
Journal Detail:
Title:  JAMA dermatology     Volume:  149     ISSN:  2168-6084     ISO Abbreviation:  JAMA Dermatol     Publication Date:  2013 Apr 
Date Detail:
Created Date:  2013-06-11     Completed Date:  2013-07-30     Revised Date:  2013-12-13    
Medline Journal Info:
Nlm Unique ID:  101589530     Medline TA:  JAMA Dermatol     Country:  United States    
Other Details:
Languages:  eng     Pagination:  402-10     Citation Subset:  AIM; IM    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:
Aged
Aged, 80 and over
Carcinoma, Squamous Cell / pathology*
Female
Humans
Male
Medical Oncology / methods*
Neoplasm Recurrence, Local / pathology
Neoplasm Staging / methods*
Prognosis
Reproducibility of Results
Retrospective Studies
Skin Neoplasms / pathology*
Societies, Medical*
United States
Grant Support
ID/Acronym/Agency:
5-T32-AR074465/AR/NIAMS NIH HHS
Comments/Corrections
Comment In:
JAMA Dermatol. 2013 Apr;149(4):472-4   [PMID:  23325339 ]

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  The Clinical Anatomy and Pathology of the Human Arterial Valves: Implications for Repair or Replacem...
Next Document:  Pulling the Levers of Photophysics: How Structure Controls the Rate of Energy Dissipation.